Mode
Text Size
Log in / Sign up

Wearable monitoring reduced prolonged hospital stay from 24% to 7% in lung cancer surgery cohortsWearable monitors and rehab support may help lung cancer patients recover faster after surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that wearable monitoring reduced prolonged hospital stay from 24% to 7% but evidence is sparse.

This narrative synthesis evaluates eight reports representing seven independent cohorts of adults undergoing lung cancer surgery or clinically relevant pulmonary resection. The scope covers preoperative, in-hospital, or post-discharge phases involving wearable-based activity, physiologic monitoring, or rehabilitation support. The review does not report a specific comparator or primary outcome but analyzes secondary outcomes including prolonged hospital stay, postoperative length of stay, chest tube duration, recovery outcomes, feasibility, data transmission, and agreement with electronic health record measurements.

Key results indicate that prolonged hospital stay greater than five days was reduced from 24% to 7% with a p-value of 0.021. Postoperative length of stay and chest tube duration were shorter in the intervention group, though specific effect sizes were not reported. Associations between perioperative step counts and recovery outcomes were described as weak but significant with a positive direction.

The authors highlight limitations including clinical and methodological heterogeneity, sparse evidence, heterogeneous evidence, and often indirect evidence. Safety data, adverse events, serious adverse events, discontinuations, and tolerability were not reported. The review concludes that findings should be interpreted as hypothesis-generating rather than sufficient to support routine clinical implementation due to these constraints.

A new review looked at eight different reports involving adults who had lung cancer surgery. The studies checked if using wearable devices or getting extra rehab help made a difference. Most of the data came from hospitals or right after patients went home.

The results showed big improvements for some patients. Those who used the special monitoring tools had fewer long hospital stays. Specifically, the chance of staying in the hospital for more than five days dropped from twenty-four percent to just seven percent. This change was considered very important by the researchers.

Other benefits included shorter times for chest tubes to stay in place. The review also found that steps taken around the time of surgery were linked to better recovery. However, the connection was not very strong in every single case. The evidence was mixed because the studies were not all exactly the same.

Experts say these findings are interesting but not ready for everyone yet. The information is too limited to say these tools should be used in every hospital right now. More research is needed to prove they work for all patients safely.

What this means for you:
Wearable monitors and rehab support may help lung cancer patients recover faster after surgery, though more research is needed.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Enhanced Recovery After Surgery (ERAS) pathways in thoracic oncology emphasize early mobilization and objective discharge readiness, but perioperative functional recovery is often assessed intermittently. Wearable devices may provide continuous, objective recovery metrics. We conducted a PRISMA 2020-based systematic review registered in PROSPERO (CRD420261325339). PubMed, Scopus, and Web of Science Core Collection were searched for English-language studies published between February 2, 1996 and February 2, 2026. Eligible reports included adults undergoing lung cancer surgery or clinically relevant pulmonary resection and evaluated wearable-based activity, physiologic monitoring, or rehabilitation support across the preoperative, in-hospital, or post-discharge phases. Risk of bias was assessed using RoB 2, ROBINS-I, or design-appropriate feasibility and measurement appraisal. Certainty of evidence was qualitatively informed by GRADE principles, and findings were synthesized narratively because of clinical and methodological heterogeneity. Eight reports representing seven independent cohorts were included: two randomized trials, one nonrandomized trial with historical controls, two prospective observational studies, two companion single-arm preoperative feasibility/effectiveness reports, and one development/usability agreement study. In the Move For Surgery RCT, wearable-enhanced preconditioning reduced prolonged hospital stay >5 days from 24% to 7% (12/50 vs 3/45; p=0.021). A digital chest drainage RCT reported shorter postoperative length of stay and chest tube duration in the intervention group, although the cohort was not restricted to lung cancer. Observational studies showed weak but significant associations between perioperative step counts and recovery outcomes. Feasibility studies supported device use and data transmission, while a smartwatch-ePRO study showed close agreement with electronic health record measurements. Wearable-based perioperative monitoring appears feasible and may provide objective recovery signals in lung cancer surgery. However, current evidence remains sparse, heterogeneous, and often indirect. Findings should be interpreted as hypothesis-generating rather than sufficient to support routine clinical implementation. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261325339, identifier CRD420261325339.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.